Pathology Image Detail

Caption

These animals were injected with BrdUrd (10 mg/kg body weight) 1 h before death, and analysis of BrdUrd incorporation demonstrated a significantly higher S-phase fraction (P < 0.05 for three matched pairs) in the Rb+/-; ARF-/- sample (D) relative to the Rb+/- control (C).

Description

"Midsagittal section of pituitary tumors stained with BrdUrd showing 2.3 +/- 0.6% positive nuclei. Only low level of apoptosis observed by both TUNEL staining and study of H&E stained slides for hallmarks of apoptosis such as marginated chromatin and fragmented nuclei."

Age at Necropsy

6.5 month

Notes

Text and Fig 2c original source.

Contributor

Tsai KY (J:81016)

Pathologist

Tsai KY (J:81016)

Copyright

This image is from Tsai KY, Proc Natl Acad Sci USA 2002 Dec 24;99(26):16865-70. Copyright 2002 National Academy of Sciences, U.S.A.

Method

H&E
Image Probes

Type: antibody

Name
anti-Bromodeoxyuridine (BrdUrd) (M0744)
Target
Bromodeoxyuridine (BrdUrd)
Notes
Mouse IgG1 monocolonal antibody. Clone Bu20a.

Model

MMHC ID
MTB:22217
Tumor Name
Pituitary gland - Pars intermedia • tumor
Treatment Type
None (spontaneous)
Tumor Synonyms
intermediate lobe pituitary tumor
Organ Affected
Pituitary gland - Pars intermedia
Frequency
very high
Reference
J:81016

Strain

Strain
B6;129-Rb1tm1Tyj/+
Strain Types
targeted mutation (knockout)
General Note
Heterozygous mice. The genetic background of these mice is referred to as 129 X C57BL/6 and includes a mixture of C57BL/6, 129S2/SvPas, and possibly some other substrain of 129.
Strain Synonyms
Rb+/-
Strain Sex
Unspecified
Reproductive Status
reproductive status not specified